Global Progressive Supranuclear Palsy Treatment Market to Surpass US$ 20.68 Million by 2027, Says Coherent Market Insights (CMI)

Global Progressive Supranuclear Palsy Treatment Market to Surpass US$ 20.68 Million by 2027, Says Coherent Market Insights (CMI)




Global Progressive Supranuclear Palsy Treatment Market to Surpass US$ 20.68 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE–(BUSINESS WIRE)–#CurePSP–According to Coherent Market Insights, the global progressive supranuclear palsy treatment market is estimated to be valued at US$ 14.38 million in 2020 and is expected to exhibit a CAGR of 5.3% during the forecast period (2020-2027).

Key Trends and Analysis:

Key trends in the market include rising incidence of progressive supranuclear palsy and ongoing research and development for treatment.

Market players are actively focusing research and development for progressive supranuclear palsy treatment for cost effective and quality treatment. For instance, in July 2018, Asceneuron, a Switzerland-based biotechnology company received orphan drug designation, for its lead drug ASN120290 from the U.S. Food and Drug Administration (FDA). ASN120290’s therapeutic potential has been demonstrated in pre-clinical studies, indicated for the treatment of rare neurodegenerative disease, progressive supranuclear palsy (PSP).

However, lack of knowledge and inadequate research and development for treatment is expected to hinder the market growth. The ongoing clinical trials are lacking in identification of disease-modifying therapies often targeting the underlying tau pathology.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4277

Key Market Takeaways:

The global progressive supranuclear palsy (PSP) treatment market is expected to exhibit a CAGR of 5.3% during the forecast period, owing to rising incidence of PSP globally. For instance, according to the National Center for Biotechnology Information (NCBI), an article published in July 2020, reports that globally the prevalence of progressive supranuclear palsy is 5.8 to 6.5 per 100,000 persons, and the annual incidence rate ranges from 0.3 to 0.4 per 100,000 persons.

Key players in the market are focusing on drug development for the treatment of progressive supranuclear palsy (PSP), which is expected to propel the market growth during the forecast period. For instance, in February 2020, Retrotope Inc., announced that U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted orphan drug designation for its RT00, a chemically-modified polyunsaturated fatty acid drug for the treatment of PSP.

Competitive Landscape:

Key players operating in the global progressive supranuclear palsy treatment market include AbbVie Inc., Acorda Therapeutics Inc., Biogen Inc., Bristol-Myers Squibb Co., Merck & Co. Inc., UCB Biopharma, AlzProtect, Asceneuron Therapeutics, TauRx Pharmaceuticals, GlaxoSmithKline PLC, Novartis AG, and Teva Pharmaceutical Industries Ltd.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4277

Market Segmentation:

  • Global Progressive Supranuclear Palsy Treatment Market, By Drug Type:
  • Dopamine
  • Anticholinergic Agents
  • Tricyclic Antidepressants
  • Others
  • Global Progressive Supranuclear Palsy Treatment  Market, By Distribution Channel:

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Progressive Supranuclear Palsy Treatment  Market, By Region:

    • North America

      • By Country:

        • U.S.
        • Canada
    • Latin America

      • By Country:

        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe

      • By Country:

        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific

      • By Country:

        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East

      • By Country:

        • GCC
        • Israel
        • Rest of Middle East
    • Africa

      • By Country/Region:

        • South Africa
        • Central Africa
        • North Africa

Related Market Intelligence Report:

Visceral Pain Treatment Market, by Drug Type (Pain modifiers (Tricyclic Anticonvulsant and Tricyclic Antidepressants), Analgesics (Narcotics and NSAID), and Others), by Indication (Chronic prostatitis, Interstitial cystitis, Crohn’s Disease, and Irritable Bowel Syndrome), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Channels), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/visceral-pain-treatment-market-4095

Bipolar Disorder Treatment Market, By Drug Class (Antipsychotics, Antidepressants, Mood Stabilizers, and Anti-anxiety Drugs and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/bipolar-disorders-treatment-market-2605

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:
US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter